{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:17:43Z","timestamp":1760188663764},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,7,1]],"date-time":"1988-07-01T00:00:00Z","timestamp":583718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Springer Semin Immunopathol"],"published-print":{"date-parts":[[1988,7]]},"DOI":"10.1007\/bf02054025","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T03:11:12Z","timestamp":1123816272000},"page":"75-89","source":"Crossref","is-referenced-by-count":13,"title":["Clearance of cryoglobulins in man"],"prefix":"10.1007","volume":"10","author":[{"given":"Yin C.","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurg A.","family":"Schifferli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02054025_CR1","first-page":"483","volume":"15","author":"V Balazs","year":"1967","unstructured":"Balazs V, Frohlich MM (1967) Anticomplementary activity of isolated cryoglobulins of different types. Protides Biol Fluids 15: 483","journal-title":"Protides Biol Fluids"},{"key":"BF02054025_CR2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.1780271008","volume":"27","author":"G Balestrieri","year":"1984","unstructured":"Balestrieri G, Tincani A, Migliorini P, Ferri C, Cattaneo R, Bombardieri S (1984) Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. Arthritis Rheum 27: 1130","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1152\/jappl.1948.1.1.3","volume":"1","author":"HC Bazett","year":"1948","unstructured":"Bazett HC, Love L, Neton M, Eisenberg L, Day R, Forster R (1948) Temperature changes in blood flowing in arteries and veins in man. J Appl Physiol 1: 3","journal-title":"J Appl Physiol"},{"key":"BF02054025_CR4","first-page":"91","volume":"17","author":"NE Bianco","year":"1974","unstructured":"Bianco NE, Dobkin LW, Schur PH (1974) Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol 17: 91","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.1780240313","volume":"24","author":"DA Birchmore","year":"1981","unstructured":"Birchmore DA, Taylor RP, Waller SJ, Davis JS, Morley KW (1981) Interaction between rheumatoid factor and antibody\/DNA complexes. Arthritis Rheum 24: 527","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780250307","volume":"25","author":"WK Bolton","year":"1982","unstructured":"Bolton WK, Schrock JH, Davis JS (1982) Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus. Arthritis Rheum 25: 297","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR7","first-page":"537","volume":"4","author":"J Bradley","year":"1969","unstructured":"Bradley J, Normansell D, Rowe DS (1969) The metabolism of autologous IgM and 19S rheumatoid factor in rheumatoid arthritis. Clin Exp Immunol 4: 537","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Davon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775","journal-title":"Am J Med"},{"key":"BF02054025_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-1759(84)90140-6","volume":"68","author":"DA Carson","year":"1984","unstructured":"Carson DA (1984) Increase in the complement-fixing ability of murine IgG anti-lymphocyte antibodies by addition of monoclonal IgM rheumatoid factors. J Immunol Methods 68: 103","journal-title":"J Immunol Methods"},{"key":"BF02054025_CR10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4049\/jimmunol.129.4.1485","volume":"129","author":"A Circolo","year":"1982","unstructured":"Circolo A, Borsos T (1982) C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the cell. J Immunol 129: 1485","journal-title":"J Immunol"},{"key":"BF02054025_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bj1450177","volume":"145","author":"M Colomb","year":"1975","unstructured":"Colomb M, Porter RR (1975) Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement. Biochem J 145: 177","journal-title":"Biochem J"},{"key":"BF02054025_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI110764","volume":"71","author":"JB Cornacoff","year":"1983","unstructured":"Cornacoff JB, Hebert LA, Smead WL, VanAman ME, Birmingham DJ, Waxmann FJ (1983) Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 71: 236","journal-title":"J Clin Invest"},{"key":"BF02054025_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-1229(87)90167-X","volume":"42","author":"FG Cosio","year":"1987","unstructured":"Cosio FG, Hebert LA, Birmingham DJ, Dorval BL, Bakaletz AP, Kujala GA, Edberg JC, Taylor RP (1987) Clearance of human antibody\/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol 42: 1","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02054025_CR14","first-page":"405","volume":"23","author":"JJ Cream","year":"1972","unstructured":"Cream JJ, Howard A, Virella C (1972) IgG heavy chain sub classes in mixed cryoglobulins. Immunology 23: 405","journal-title":"Immunology"},{"key":"BF02054025_CR15","first-page":"555","volume":"55","author":"G Doekes","year":"1985","unstructured":"Doekes G, Schouten J, Cats A, Daha MR (1985) Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor. Immunology 55: 555","journal-title":"Immunology"},{"key":"BF02054025_CR16","first-page":"483","volume":"15","author":"P Druet","year":"1973","unstructured":"Druet P, Leton Turier L, Contet A, Mandet C (1973) Cryoglobulinaemia in human renal diseases. A study of seventy six cases. Clin Exp Immunol 15: 483","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.139.4.1240","volume":"139","author":"JC Edberg","year":"1987","unstructured":"Edberg JC, Kujala G, Taylor RP (1987) Rapid immune adherence reactivity of nascent, soluble antibody\/DNA immune complexes in the circulation. J Immunol 139: 1240","journal-title":"J Immunol"},{"key":"BF02054025_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.145.2.357","volume":"145","author":"AG Ehlenberger","year":"1977","unstructured":"Ehlenberger AG, Nussenzweig V (1977) The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med 145: 357","journal-title":"J Exp Med"},{"key":"BF02054025_CR19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0019-2791(76)90347-5","volume":"13","author":"R Eisenberg","year":"1976","unstructured":"Eisenberg R (1976) The specificity and polyvalency of binding of a monoclonal rheumatoid factor. Immunochemistry 13: 355","journal-title":"Immunochemistry"},{"key":"BF02054025_CR20","first-page":"285","volume":"59","author":"CJ Elson","year":"1985","unstructured":"Elson CJ, Carter SA, Cotterell BJ, Scott DGI, Bacon PA (1985) Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis. Clin Exp Immunol 59: 285","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.152.1.20","volume":"152","author":"DT Fearon","year":"1980","unstructured":"Fearon DT (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucoyte, B lymphocyte, and monocyte. J Exp Med 152: 20","journal-title":"J Exp Med"},{"key":"BF02054025_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0167-5699(84)90044-6","volume":"5","author":"DT Fearon","year":"1984","unstructured":"Fearon DT (1984) Cellular receptors for fragments of the third component of complement. Immunol Today 5: 105","journal-title":"Immunol Today"},{"key":"BF02054025_CR23","doi-asserted-by":"crossref","unstructured":"Feinstein A, Richardson NE, Gorick BD, Hughes-Jones NC (1983) Immunoglobulin M conformational change is a signal for complement activation. Protein confirmation as an immunological signal. In: Celeda F, Schumaker VN, Sercarz EE (eds). Plenum Press, New York, pp 47","DOI":"10.1007\/978-1-4613-3778-2_6"},{"key":"BF02054025_CR24","first-page":"165","volume":"36","author":"M Floyd","year":"1979","unstructured":"Floyd M, Tesar JT (1979) The role of IgM rheumatoid factor in experimental immune vasculitis. Clin Exp Immunol 36: 165","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR25","first-page":"285","volume":"51","author":"PM Ford","year":"1983","unstructured":"Ford PM, Kosatka I (1983) In situ immune complex formation in the mouse glomerulus: reactivity with human IgM rheumatoid and the effect on subsequent immune complex deposition. Clin Exp Immunol 51: 285","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR26","first-page":"337","volume":"31","author":"A Fornasieri","year":"1987","unstructured":"Fornasieri A, Sinico RA, Winearls CG, Grennan DG, Sabadini E, Castiglione A, d'Amico G, Sissons JP (1987) Identification of glomerular immune deposits in essential mixed cryoglobulinemia \u2014 glomerulonephritis. Kidney Int 31: 337 [abstr]","journal-title":"Kidney Int"},{"key":"BF02054025_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000233759","volume":"77","author":"MM Frank","year":"1985","unstructured":"Frank MM (1985) New developments in immunopathology with special reference to complement and immune complexes. Int Arch Allergy Appl Immunol 77: 89","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"BF02054025_CR28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7326\/0003-4819-98-2-218","volume":"98","author":"MM Frank","year":"1983","unstructured":"Frank MM, Lawley TJ, Hamburger MI, Brown EJ (1983) Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med 98: 206","journal-title":"Ann Intern Med"},{"key":"BF02054025_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000166650","volume":"2","author":"MJ Germain","year":"1982","unstructured":"Germain MJ, Anderson RW, Kaene WF (1982) Renal disease in cryoglobulinemia type II: response to therapy. A case report and review of the literature. Am J Nephrol 2: 221","journal-title":"Am J Nephrol"},{"key":"BF02054025_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-94-009-4289-9_13","volume-title":"Antiglobulins, cryoglobulins and glomerulonephritis","author":"I Gigli","year":"1986","unstructured":"Gigli I (1986) Complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement). In: Ponticelli C, Minelli L, d'Amico G (eds) Antiglobulins, cryoglobulins and glomerulonephritis. Martins Nijhoff, Dordrecht Boston Lancaster, pp 135\u2013146"},{"key":"BF02054025_CR31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/bj1750675","volume":"175","author":"JWF Goers","year":"1978","unstructured":"Goers JWF, Porter RR (1978) The assembly of early components of complement on antibody- antigen aggregates and on antibody-coated erythrocytes. Biochem J 175: 675","journal-title":"Biochem J"},{"key":"BF02054025_CR32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","volume":"69","author":"PD Gorevic","year":"1980","unstructured":"Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC (1980) Mixed cryoglobulinemia: clinical aspects and long term follow up of 40 patients. Am J Med 69: 287","journal-title":"Am J Med"},{"key":"BF02054025_CR33","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.112.5.1939","volume":"112","author":"AO Haakenstad","year":"1974","unstructured":"Haakenstad AO, Mannik M (1974) Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol 112: 1939","journal-title":"J Immunol"},{"key":"BF02054025_CR34","first-page":"81","volume":"24","author":"MI Hamburger","year":"1981","unstructured":"Hamburger MI, Field TR, Lawley TJ, Hall R, Kimberly RP, Plotz P, Frank MM (1981) Reticuloendothelial system C3b receptor function in systemic lupus erythematosus. Arthritis Rheum 24: S81 [abstr]","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1172\/JCI105541","volume":"46","author":"LB Hanauer","year":"1967","unstructured":"Hanauer LB, Christian CL (1967) Studies of cryoproteins in systemic lupus erythematosus. J Clin Invest 46: 400","journal-title":"J Clin Invest"},{"key":"BF02054025_CR36","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.4049\/jimmunol.133.4.2079","volume":"133","author":"C Horgan","year":"1984","unstructured":"Horgan C, Burge J, Crawford L, Taylor RP (1984) The kinetics of3H-dsDNA\/anti-DNA immune complex formation, binding by red cells and release into serum: effects of DNA molecular weight and conditions of antibody excess. J Immunol 133: 2079","journal-title":"J Immunol"},{"key":"BF02054025_CR37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1084\/jem.155.5.1427","volume":"155","author":"K Iida","year":"1982","unstructured":"Iida K, Mornaghi R, Nussenzweig V (1982) Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 155: 1427","journal-title":"J Exp Med"},{"key":"BF02054025_CR38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI109212","volume":"62","author":"CJ Jaffe","year":"1978","unstructured":"Jaffe CJ, Vierling JM, Jones EA, Lawley TJ, Frank MM (1978) Receptor-specific clearance by the reticuloendothelial system in chronic liver disease: demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest 62: 1069","journal-title":"J Clin Invest"},{"key":"BF02054025_CR39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-94-009-4289-9_8","volume-title":"Antiglobulins, cryoglobulins and glomerulonephritis","author":"PH Lambert","year":"1986","unstructured":"Lambert PH, Izui S, Gyotoku Y, Abdelmoula M, Spertini F (1986) Experimental analysis of the generation of pathogenic immune complexes resulting from immunoglobulin interactions. In: Ponticelli C, Minelli L, d'Amico G (eds) Antiglobulins, cryoglobulins and glomerulonephritis. Martins Nijhoff, Dordrecht Boston Lancaster, pp 79\u201385"},{"key":"BF02054025_CR40","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4049\/jimmunol.123.3.1388","volume":"123","author":"SK Law","year":"1979","unstructured":"Law SK, Lichtenberg NA, Levine RP (1979) Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol 123: 1388","journal-title":"J Immunol"},{"key":"BF02054025_CR41","first-page":"133","volume":"68","author":"S Lobatto","year":"1987","unstructured":"Lobatto S, Daha MR, Voetman AA, Evers-Schouten JH, van Es AA, Pauwels EKJ, van Es LA (1987) Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol 68: 133","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.1979.159","volume":"16","author":"CM Lockwood","year":"1979","unstructured":"Lockwood CM (1979) Lymphoma, cryoglobulinaemia and renal disease. Kidney Int 16: 522","journal-title":"Kidney Int"},{"key":"BF02054025_CR43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM197903083001003","volume":"300","author":"CM Lockwood","year":"1979","unstructured":"Lockwood CM, Worlledge S, Nicolas A, Cotton C, Peters DK (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300: 524","journal-title":"N Engl J Med"},{"key":"BF02054025_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1088\/0031-9155\/2\/1\/305","volume":"2","author":"CME Matthews","year":"1957","unstructured":"Matthews CME (1957) The theory of tracer experiments with I-labelled plasma proteins. Phys Med Biol 2: 36","journal-title":"Phys Med Biol"},{"key":"BF02054025_CR45","first-page":"566","volume":"75","author":"RM McIntosh","year":"1970","unstructured":"McIntosh RM, Kaufman DB, Kulvinskas C, Grossman BJ (1970) Cryoglobulins. 1. Studies on the nature, incidence and clinical significance of serum cryoproteins in glomerulonephritis. J Lab Clin Med 75: 566","journal-title":"J Lab Clin Med"},{"key":"BF02054025_CR46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/eji.1830130607","volume":"13","author":"RG Medicus","year":"1983","unstructured":"Medicus RG, Melamed J, Arnaout MA (1983) Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules. Eur J Immunol 13: 465","journal-title":"Eur J Immunol"},{"key":"BF02054025_CR47","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.156.6.1739","volume":"156","author":"ME Medof","year":"1982","unstructured":"Medof ME, Iida K, Mold C, Nussenzweig V (1982) Unique role of the complement receptor CR1 in the degradation of C3B associated with immune complexes. J Exp Med 156: 1739","journal-title":"J Exp Med"},{"key":"BF02054025_CR48","first-page":"715","volume":"48","author":"ME Medof","year":"1982","unstructured":"Medof ME, Prince GM, Oger JJF (1982) Kinetics of interactions of immune complexes with complement receptors on human blood cells: modifications of complexes during interaction with red cells. Clin Exp Immunol 48: 715","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","volume":"40","author":"M Meltzer","year":"1966","unstructured":"Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinaemia \u2014 a clinical and laboratory study. Am J Med 40: 837","journal-title":"Am J Med"},{"key":"BF02054025_CR50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(81)90882-5","volume":"II","author":"Y Miyakawa","year":"1981","unstructured":"Miyakawa Y, Yameda A, Kosada K (1981) Defective immune adherence (C3b) receptor on red cells from patients with systemic lupus erythematosus. Lancet II: 493","journal-title":"Lancet"},{"key":"BF02054025_CR51","first-page":"465","volume":"107","author":"TL Moore","year":"1986","unstructured":"Moore TL, Dorner RW, Zuckner J (1986) 19S IgM rheumatoid factor \u2014 7SIgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis. J Lab Clin Med 107: 465","journal-title":"J Lab Clin Med"},{"key":"BF02054025_CR52","first-page":"429","volume":"54","author":"JK Naama","year":"1983","unstructured":"Naama JK, Mitchell WS, Whaley KS (1983) Inhibition of complement-mediated solubilisation of antigen-antibody complexes by sera from patients with rheumatoid arthritis. Clin Exp Immunol 54: 429","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR53","first-page":"177","volume":"12","author":"JB Natvig","year":"1972","unstructured":"Natvig JB, Gaarder PI, Turner MW (1972) IgG antigens of the C2 and 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol 12: 177","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR54","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4049\/jimmunol.123.4.1839","volume":"123","author":"SL Newman","year":"1979","unstructured":"Newman SL, Johnston RB (1979) Role of binding through C3b and IgG receptors in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol 123: 1839","journal-title":"J Immunol"},{"key":"BF02054025_CR55","doi-asserted-by":"crossref","unstructured":"Ng YC, Peters DK, Walport MJ (1987) Monoclonal rheumatoid factor-IgG immune complexes: poor fixation of opsonic C4 and C3 despite efficient complement activation. Arthritis Rheum (in press)","DOI":"10.1002\/art.1780310114"},{"key":"BF02054025_CR56","first-page":"23","volume":"30","author":"YC Ng","year":"1987","unstructured":"Ng YC, Schifferli JA, Paccaud JP, Walport MJ (1987) Clearance mechanisms of125I-tetanus toxoid- anti-tetanus toxoid immune complexes in vivo in humans. Arthritis Rheum 30: S23 [abstr]","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR57","unstructured":"Ng YC, Schifferli JA, Walport MJ (1988) Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. Clin Exp Immunol (in press)"},{"key":"BF02054025_CR58","first-page":"113","volume":"9","author":"B Nosslin","year":"1973","unstructured":"Nosslin B (1973) Analysis of disappearance time curves after single injection of labelled proteins. Ciba Found Symp 9: 113","journal-title":"Ciba Found Symp"},{"key":"BF02054025_CR59","first-page":"468","volume":"69","author":"JP Paccaud","year":"1987","unstructured":"Paccaud JP, Steiger G, Sj\u00f6holm AG, Spaeth PJ, Schifferli JA (1987) Tetanus toxoid- anti-tetanus toxoid complexes: a potential model to study the human complement transport system for immune complex in humans. Clin Exp Immunol 69: 468","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-1229(83)90016-8","volume":"29","author":"R Powell","year":"1983","unstructured":"Powell R, Agnello V (1983) Characterization of complement fixing activity and cross-idiotypes in rheumatoid factors in idiopathic mixed cryoglobulinaemia. Clin Immunol Immunopathol 29: 146","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02054025_CR61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1525-1594.1981.tb03986.x","volume":"5","author":"CD Pusey","year":"1981","unstructured":"Pusey CD, Schifferli JA, Lockwood CM, Peters DK (1981) Use of plasma exchange in the management of mixed essential cryoglobulinaemia. Artif Organs 5 (s): 183","journal-title":"Artif Organs"},{"key":"BF02054025_CR62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(08)60341-7","volume":"37","author":"GD Ross","year":"1985","unstructured":"Ross GD, Medof ME (1985) Membrane complement receptors specific for bound fragments of C3. Adv Immunol 37: 217","journal-title":"Adv Immunol"},{"key":"BF02054025_CR63","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.129.5.2051","volume":"129","author":"GD Ross","year":"1982","unstructured":"Ross GD, Lambris JD, Cain JA, Newman SL (1982) Generation of three different fragments of bound C3 with purified I or serum. Requirements for factor H vs CR1 cofactor activity. J Immunol 129: 2051","journal-title":"J Immunol"},{"key":"BF02054025_CR64","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.135.3.2005","volume":"135","author":"GD Ross","year":"1985","unstructured":"Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ (1985) Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and\/or complement activation. J Immunol 135: 2005","journal-title":"J Immunol"},{"key":"BF02054025_CR65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2362.1972.tb00570.x","volume":"2","author":"U Rother","year":"1972","unstructured":"Rother U, Rother K, Flad HD, Miescher PA (1972) Bithermic complement activation in cryoglobulinaemic serum. Eur J Clin Invest 2: 59","journal-title":"Eur J Clin Invest"},{"key":"BF02054025_CR66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005792-197554020-00004","volume":"54","author":"S Ruddy","year":"1975","unstructured":"Ruddy S, Carpenter CB, Chin KW, Knostman JN, Soter NA, G\u00f6tze O, M\u00fcller-Eberhard HJ, Austen KF (1975) Human complement metabolism: an analysis of 144 studies. Medicine (Baltimore) 54: 165","journal-title":"Medicine (Baltimore)"},{"key":"BF02054025_CR67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/art.1780250208","volume":"25","author":"UK Sabharwal","year":"1982","unstructured":"Sabharwal UK, Vaughan JH, Fong S, Bennett PH, Carson DA, Curd JG (1982) Activation of the classical pathway of complement by rheumatoid factors. Assessment by radio-immunoassay for C4. Arthritis Rheum 25: 161","journal-title":"Arthritis Rheum"},{"key":"BF02054025_CR68","first-page":"555","volume":"47","author":"JA Schifferli","year":"1982","unstructured":"Schifferli JA, Woo P, Peters DK (1982) Complement-mediated inhibition of immune precipitation. I Role of the classical and alternative pathways. Clin Exp Immunol 47: 555","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR69","first-page":"305","volume":"51","author":"JA Schifferli","year":"1983","unstructured":"Schifferli JA, Amos N, Pusey CD, Sissons JGP, Peters DK (1983) Metabolism of IgG in type II mixed essential cryoglobulinaemia-autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates. Clin Exp Immunol 51: 305","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR70","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI112217","volume":"76","author":"JA Schifferli","year":"1985","unstructured":"Schifferli JA, Steiger G, Haultmann G, Spaeth PJ, Sj\u00f6 holm AG (1985) Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states: difference between inhibition of immune precipitation and solubilization. J Clin Invest 76: 2127","journal-title":"J Clin Invest"},{"key":"BF02054025_CR71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1523-1747.ep12277069","volume":"85","author":"JA Schifferli","year":"1985","unstructured":"Schifferli JA, Steiger G, Polla L, Didierjean L, Saurat JH (1985) Activation of the alternative pathway of complement by skin immune deposits. J Invest Dermatol 85: 407","journal-title":"J Invest Dermatol"},{"key":"BF02054025_CR72","first-page":"448","volume":"315","author":"JA Schifferli","year":"1986","unstructured":"Schifferli JA, Ng YC, Peters DK (1986) The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315: 448","journal-title":"N Engl J Med"},{"key":"BF02054025_CR73","first-page":"188","volume":"69","author":"JA Schifferli","year":"1987","unstructured":"Schifferli JA, Pascual M, Steiger G, Schapira M, Ryser JE, Estreicher J, Dash A (1987) Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement. Clin Exp Immunol 69: 188","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR74","doi-asserted-by":"crossref","unstructured":"Schifferli JA, Ng YC, Estreicher J, Walport MJ (1988). The clearance of tetanus toxoid- anti-tetanus toxoid immune complexes from the circulation of humans: complement- and erythrocyte CR1-dependent mechanisms. J Immunol (in press)","DOI":"10.4049\/jimmunol.140.3.899"},{"key":"BF02054025_CR75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.132.4.673","volume":"132","author":"FR Schmid","year":"1970","unstructured":"Schmid FR, Roitt IM, Rocha MJ (1970) Complement fixation by two-component antibody system: immunoglobulin G and Immunoglobulin M anti-globulin (rheumatoid factor). Paradoxical effect related to immunoglobulin G concentration. J Exp Med 132: 673","journal-title":"J Exp Med"},{"key":"BF02054025_CR76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(81)90941-7","volume":"II","author":"I Siegal","year":"1981","unstructured":"Siegal I, Liu TTL, Gleicher RN (1981) The red cell immune system. Lancet II: 556","journal-title":"Lancet"},{"key":"BF02054025_CR77","first-page":"6","volume":"130","author":"RP Taylor","year":"1983","unstructured":"Taylor RP, Burge J, Horgan C, Shasby DM (1983) The complement-mediated binding of soluble antibody\/dsDNA immune complexes to human neutrophils. J Immunol 130: 6","journal-title":"J Immunol"},{"key":"BF02054025_CR78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI111660","volume":"75","author":"RP Taylor","year":"1985","unstructured":"Taylor RP, Horgan C, Hooper M, Burge J (1985) Dynamics of interaction between complement- fixing antibody\/dsDNA immune complexes and erythrocytes: in vitro studies and potential general applications to clinical immune complex testing. J Clin Invest 75: 102","journal-title":"J Clin Invest"},{"key":"BF02054025_CR79","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.4049\/jimmunol.136.10.3785","volume":"136","author":"RP Taylor","year":"1986","unstructured":"Taylor RP, Kujala G, Edberg JC, Foreman P, Davis JS, Wright E (1986) The kinetic of clearance of human antibody\/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies. J Immunol 136: 3785","journal-title":"J Immunol"},{"key":"BF02054025_CR80","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.105.5.1206","volume":"105","author":"JT Tesar","year":"1970","unstructured":"Tesar JT, Schmid FR (1970) Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor. J Immunol 105: 1206","journal-title":"J Immunol"},{"key":"BF02054025_CR81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0065-2776(08)60800-7","volume":"28","author":"AN Theofilopoulos","year":"1979","unstructured":"Theofilopoulos AN, Dixon FJ (1979) The biology and detection of immune complexes. Adv Immunol 28: 89","journal-title":"Adv Immunol"},{"key":"BF02054025_CR82","first-page":"387","volume":"45","author":"F Uher","year":"1982","unstructured":"Uher F, Dobronyi I, Gergely J (1982) Binding of different ligants to IgM-Fc receptors of rat leucocytes. Immunology 45: 387","journal-title":"Immunology"},{"key":"BF02054025_CR83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.1830080412","volume":"8","author":"L Van Snick","year":"1978","unstructured":"Van Snick L, Van Roost E, Markowetz B (1978) Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes. Eur J Immunol 8: 279","journal-title":"Eur J Immunol"},{"key":"BF02054025_CR84","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI106567","volume":"50","author":"TA Waldmann","year":"1971","unstructured":"Waldmann TA, Johnson JS, Talal N (1971) Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its interaction with an IgG-reactive monoclonal IgM. J Clin Invest 50: 951","journal-title":"J Clin Invest"},{"key":"BF02054025_CR85","first-page":"465","volume":"60","author":"MJ Walport","year":"1985","unstructured":"Walport MJ, Peters AM, Elkon KB, Pusey CD, Lavender JP, Hughes GRV (1985) The splenic extraction ration of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone. Clin Exp Immunol 60: 465","journal-title":"Clin Exp Immunol"},{"key":"BF02054025_CR86","first-page":"547","volume":"59","author":"MJ Walport","year":"1985","unstructured":"Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ (1985) Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Inununol 59: 547","journal-title":"Clin Exp Inununol"},{"key":"BF02054025_CR87","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI111543","volume":"74","author":"FJ Waxman","year":"1984","unstructured":"Waxman FJ, Hebert LE, Cornacoff JB, VanAman ME, Smead WL, Kraut HG, Birmingham DJ, Taguiam JM (1984) Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest 74: 1329","journal-title":"J Clin Invest"},{"key":"BF02054025_CR88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1172\/JCI112306","volume":"77","author":"FJ Waxman","year":"1986","unstructured":"Waxman FJ, Hebert LA, Cosio FG, Smead WL, Van Aman ME, Taguiam JM, Birmingham DJ (1986) Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo: immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest 77: 82","journal-title":"J Clin Invest"},{"key":"BF02054025_CR89","doi-asserted-by":"crossref","unstructured":"Wilson CB, Dixon FJ (1971) Quantification of acute and chronic serum sickness in the rabbit. J Exp Med 134: 7s","DOI":"10.1084\/jem.134.3.7"},{"key":"BF02054025_CR90","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198210143071604","volume":"307","author":"JG Wilson","year":"1982","unstructured":"Wilson JG, Wong WW, Schur PH, Fearon DT (1982) Mode of inheritance of decreased C3b receptor on red cells of patients with systemic lupus erythematosus. N Engl J Med 307: 981","journal-title":"N Engl J Med"},{"key":"BF02054025_CR91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI106254","volume":"49","author":"RD Wochner","year":"1970","unstructured":"Wochner RD (1970) Hypercatabolism of normal IgG an unexpected immunoglobulin abnormality in the connective tissue diseases. J Clin Invest 49: 454","journal-title":"J Clin Invest"},{"key":"BF02054025_CR92","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.126.5.1769","volume":"126","author":"RJ Ziccardi","year":"1981","unstructured":"Ziccardi RJ (1981) Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 126: 1769","journal-title":"J Immunol"}],"container-title":["Springer Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02054025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02054025\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02054025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:19:45Z","timestamp":1683173985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02054025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,7]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,7]]}},"alternative-id":["BF02054025"],"URL":"https:\/\/doi.org\/10.1007\/bf02054025","relation":{},"ISSN":["0344-4325","1432-2196"],"issn-type":[{"value":"0344-4325","type":"print"},{"value":"1432-2196","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,7]]}}}